Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Pediatr Blood Cancer. 2019 Jan 24;66(5):e27621. doi: 10.1002/pbc.27621

FIGURE 1.

FIGURE 1.

(A) Probability of 3-year event-free survival (EFS) for the 386 patients with NHL. (B) Probability of 3-year EFS according to disease stage. (C) Probability of 3-year EFS for 208 patients with stage III disease based on the evidence of residual disease after induction.